AstraZeneca won approval for lung cancer pill Tagrisso in China

News Hour:

AstraZeneca said on Monday it had won approval for its lung cancer pill Tagrisso in China, a key market for the potential blockbuster medicine.

Tagrisso is designed to help cancer patients with certain genetic mutations that are very common in China and other parts of east Asia, reports Reuters.

Avatar

This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments

Translate this News

Join the Facebook Group

Click here to join the Facebook group of News Hour

Popular Posts

Advertisement

News of the Month

Scroll Up
%d bloggers like this: